280 related articles for article (PubMed ID: 19840825)
1. Formulation and coating of microneedles with inactivated influenza virus to improve vaccine stability and immunogenicity.
Kim YC; Quan FS; Compans RW; Kang SM; Prausnitz MR
J Control Release; 2010 Mar; 142(2):187-95. PubMed ID: 19840825
[TBL] [Abstract][Full Text] [Related]
2. Cross-protection by co-immunization with influenza hemagglutinin DNA and inactivated virus vaccine using coated microneedles.
Kim YC; Yoo DG; Compans RW; Kang SM; Prausnitz MR
J Control Release; 2013 Dec; 172(2):579-88. PubMed ID: 23643528
[TBL] [Abstract][Full Text] [Related]
3. Stability kinetics of influenza vaccine coated onto microneedles during drying and storage.
Kim YC; Quan FS; Compans RW; Kang SM; Prausnitz MR
Pharm Res; 2011 Jan; 28(1):135-44. PubMed ID: 20387097
[TBL] [Abstract][Full Text] [Related]
4. Intradermal vaccination with influenza virus-like particles by using microneedles induces protection superior to that with intramuscular immunization.
Quan FS; Kim YC; Vunnava A; Yoo DG; Song JM; Prausnitz MR; Compans RW; Kang SM
J Virol; 2010 Aug; 84(15):7760-9. PubMed ID: 20484519
[TBL] [Abstract][Full Text] [Related]
5. Dissolvable microneedle patches for the delivery of cell-culture-derived influenza vaccine antigens.
Kommareddy S; Baudner BC; Oh S; Kwon SY; Singh M; O'Hagan DT
J Pharm Sci; 2012 Mar; 101(3):1021-7. PubMed ID: 22190403
[TBL] [Abstract][Full Text] [Related]
6. Long-term protective immunity from an influenza virus-like particle vaccine administered with a microneedle patch.
Quan FS; Kim YC; Song JM; Hwang HS; Compans RW; Prausnitz MR; Kang SM
Clin Vaccine Immunol; 2013 Sep; 20(9):1433-9. PubMed ID: 23863506
[TBL] [Abstract][Full Text] [Related]
7. Improved immunogenicity of individual influenza vaccine components delivered with a novel dissolving microneedle patch stable at room temperature.
Vassilieva EV; Kalluri H; McAllister D; Taherbhai MT; Esser ES; Pewin WP; Pulit-Penaloza JA; Prausnitz MR; Compans RW; Skountzou I
Drug Deliv Transl Res; 2015 Aug; 5(4):360-71. PubMed ID: 25895053
[TBL] [Abstract][Full Text] [Related]
8. Formulation of microneedles coated with influenza virus-like particle vaccine.
Kim YC; Quan FS; Compans RW; Kang SM; Prausnitz MR
AAPS PharmSciTech; 2010 Sep; 11(3):1193-201. PubMed ID: 20676947
[TBL] [Abstract][Full Text] [Related]
9. Enhanced memory responses to seasonal H1N1 influenza vaccination of the skin with the use of vaccine-coated microneedles.
Kim YC; Quan FS; Yoo DG; Compans RW; Kang SM; Prausnitz MR
J Infect Dis; 2010 Jan; 201(2):190-8. PubMed ID: 20017632
[TBL] [Abstract][Full Text] [Related]
10. Stabilization of influenza vaccine enhances protection by microneedle delivery in the mouse skin.
Quan FS; Kim YC; Yoo DG; Compans RW; Prausnitz MR; Kang SM
PLoS One; 2009 Sep; 4(9):e7152. PubMed ID: 19779615
[TBL] [Abstract][Full Text] [Related]
11. Stability of whole inactivated influenza virus vaccine during coating onto metal microneedles.
Choi HJ; Bondy BJ; Yoo DG; Compans RW; Kang SM; Prausnitz MR
J Control Release; 2013 Mar; 166(2):159-71. PubMed ID: 23246470
[TBL] [Abstract][Full Text] [Related]
12. Insertion-responsive microneedles for rapid intradermal delivery of canine influenza vaccine.
Choi IJ; Kang A; Ahn MH; Jun H; Baek SK; Park JH; Na W; Choi SO
J Control Release; 2018 Sep; 286():460-466. PubMed ID: 30102940
[TBL] [Abstract][Full Text] [Related]
13. Microneedle delivery of trivalent influenza vaccine to the skin induces long-term cross-protection.
Kim YC; Lee SH; Choi WH; Choi HJ; Goo TW; Lee JH; Quan FS
J Drug Target; 2016 Dec; 24(10):943-951. PubMed ID: 26957023
[TBL] [Abstract][Full Text] [Related]
14. Preparation of H1N1 microneedles by a low-temperature process without a stabilizer.
Jeong HR; Park S; Park JH; Bae JY; Kim GY; Baek SK; Park MS; Park JH
Eur J Pharm Biopharm; 2019 Oct; 143():1-7. PubMed ID: 31398438
[TBL] [Abstract][Full Text] [Related]
15. Influenza subunit vaccine coated microneedle patches elicit comparable immune responses to intramuscular injection in guinea pigs.
Kommareddy S; Baudner BC; Bonificio A; Gallorini S; Palladino G; Determan AS; Dohmeier DM; Kroells KD; Sternjohn JR; Singh M; Dormitzer PR; Hansen KJ; O'Hagan DT
Vaccine; 2013 Jul; 31(34):3435-41. PubMed ID: 23398932
[TBL] [Abstract][Full Text] [Related]
16. Formulation Approach that Enables the Coating of a Stable Influenza Vaccine on a Transdermal Microneedle Patch.
Ameri M; Ao Y; Lewis H
AAPS PharmSciTech; 2021 Jun; 22(5):175. PubMed ID: 34114100
[TBL] [Abstract][Full Text] [Related]
17. Stability of influenza vaccine coated onto microneedles.
Choi HJ; Yoo DG; Bondy BJ; Quan FS; Compans RW; Kang SM; Prausnitz MR
Biomaterials; 2012 May; 33(14):3756-69. PubMed ID: 22361098
[TBL] [Abstract][Full Text] [Related]
18. Development of the novel coating formulations for skin vaccination using stainless steel microneedle.
Kim SJ; Shin JH; Noh JY; Song CS; Kim YC
Drug Deliv Transl Res; 2016 Oct; 6(5):486-97. PubMed ID: 27519363
[TBL] [Abstract][Full Text] [Related]
19. Enhanced Stability of Inactivated Influenza Vaccine Encapsulated in Dissolving Microneedle Patches.
Chu LY; Ye L; Dong K; Compans RW; Yang C; Prausnitz MR
Pharm Res; 2016 Apr; 33(4):868-78. PubMed ID: 26620313
[TBL] [Abstract][Full Text] [Related]
20. Microneedle vaccination with stabilized recombinant influenza virus hemagglutinin induces improved protective immunity.
Weldon WC; Martin MP; Zarnitsyn V; Wang B; Koutsonanos D; Skountzou I; Prausnitz MR; Compans RW
Clin Vaccine Immunol; 2011 Apr; 18(4):647-54. PubMed ID: 21288996
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]